Skip to main content
. 2022 Jan 9;25(3):571–577. doi: 10.1007/s40477-021-00625-4

Table 1.

Clinical and laboratory data of the entire cohort, of patients DVT positive and negative and of patients PE positive and negative

All
(n = 112)
DVT negative
(n = 64)
DVT positive
(n = 48)
p value PE negative
(n = 92)
PE positive
(n = 20)
p value
Age 62 ± 12 60 ± 12 64 ± 10 0.173 61 ± 11 66 ± 13 0.014
Sex male 82 (73.2) 47 (73.4) 35 (72.9) 0.559 70 (76.1) 12 (60.0) 0.167
DVT positive 34 (36.9) 14 (70.0) 0.007
ICU 76 (67.8) 47 (73.4) 29 (60.4) 0.144 67 (72.8) 9 (45.0) 0.015
Labs
 WBC (× 103/mm3) 11.7 ± 9.6 12.9 ± 12.2 10.1 ± 3.8 0.310 12.1 ± 10.3 9.8 ± 4.8 0.260
 Neutrophyles (× 103/mm3) 8.8 ± 6.3 9.73 ± 7.7 7.7 ± 4.1 0.431 9.3 ± 6.8 6.8 ± 3.8 0.176
 Lymphocytes (× 103/mm3) 2.6 ± 9.6 3.7 ± 13.2 1.27 ± 0.9 0.821 2.9 ± 10.8 1.3 ± 1.5 0.624
 PLT (× 103/mm3) 281.8 ± 129.3 282.9 ± 121.0 280.2 ± 140.8 0.878 280.8 ± 127.4 286.2 ± 141.0 0.997
 CRP (mg/L) 9.3 ± 10.3 9.6 ± 10.3 8.9 ± 10.4 0.644 9.8 ± 10.4 7.3 ± 9.8 0.158
 D-Dimer (ng/mL) 2110.6 ± 2386.4 1787.1 ± 2430.6 2576.1 ± 2269.8 0.004 2002.8 ± 2422.4 2601.2 ± 2212.6 0.030
 HB (g/dL) 10.6 ± 1.7 10.9 ± 1.8 10.2 ± 1.5 0.009 10.6 ± 1.7 10.6 ± 1.6 0.619
 ATIII (%) 192 ± 533 108 ± 75 287 ± 778 0.455 219 ± 590 77 ± 16 0.107
 a-pH 7.42 ± 0.1 7.42 ± 0.6 7.43 ± 0.6 0.433 7.43 ± 0.6 7.43 ± 0.5 0.784
 a-pO2 (mmHg) 95.5 ± 24.1 95.6 ± 26.8 93.8 ± 20.0 0.941 95.7 ± 24.9 94.1 ± 20.1 0.709
 a-pCO2 (mmHg) 45.6 ± 9.6 44.7 ± 8.6 46.8 ± 10.9 0.584 45.6 ± 9.6 45.6 ± 9.9 0.842
 a-HCO3 (mEq/L) 30.0 ± 5.1 29.8 ± 4.8 30.3 ± 5.5 0.715 30.1 ± 5.5 29.6 ± 5.3 0.696
 a-FiO2 (%) 51.7 ± 19.1 49.0 ± 18.1 55.8 ± 20.0 0.130 52.3 ± 19.2 48.8 ± 18.7 0.634
 a-SaO2 (%; IQR) 96 (96–98) 96 (95–97) 96 (95–98) 0.953 95 (94–97) 96 (94–98) 0.720

p values in bold represent statistically significant differences. “a-” = arterial blood gases test